Fine Needle Aspiration Cytology – Thyroid

THYROID
Helen H. Wang, MD, DrPH

Introduction

Thyroid nodules are common clinical findings with an estimated annual incidence rate of 4-8%.[1] At any given time, between 10 and 20 million Americans have clinically detectable thyroid nodules.[1] Thyroid fine needle aspiration (FNA) is the initial test in the management of most patients with a thyroid nodule because it is safe and inexpensive and provides better selection of patients for surgery than any other test.[2] Therefore, thyroid FNA is easily the most common type of FNA specimens in a cytology laboratory. Although it has been widely accepted and practiced since the 1970s, the processing and reporting of thyroid FNA’s are still controversial.

Specimen Collection and Processing
Thyroid FNA is obtained under the guidance of palpation or ultrasound, depending on the size of the lesion. Both are processed the same way, i.e. to either make conventional direct smears from the aspirate or to rinse the aspirate into a preservative to make a liquid-based preparation. Two studies that have compared the accuracy of ThinPrep® preparations versus conventional smears for thyroid FNA agreed that these two methods had comparable accuracy for thyroid neoplasms,[3, 4] although one of them showed ThinPrep preparations to have lower overall correlation with histologic diagnosis than direct smears, especially in detecting chronic lymphocytic thyroiditis (62% by ThinPrep versus 92% by direct smears).[4] In addition, some authors have suggested that ThinPrep preparations do not detect diffuse or watery colloid.[3, 5] In study by Tulecke, et al. “tissue-paper-like material” on ThinPrep was found to be associated with abundant colloid on histology and probably represents watery colloid. [6] Overall, colloid seems to be present in less quantity on ThinPrep than on conventional smears. However, ThinPrep is superior to conventional smears, whether fixed in alcohol or left to air-dry, in demonstrating nuclear features that are crucial in the diagnosis of papillary carcinoma. ThinPrep on the other hand appears to break up follicles and presents follicular cells in sheets, groups or even singly more readily than on conventional smears.

Reporting
Many reporting schemes have been proposed and used in the literature. We have found a reporting scheme based on the probability of finding carcinoma on histology to be helpful to both pathologists and clinicians.

Positive for malignancy
Specimens in this category represent those cases in which a malignancy is found on resections virtually 100% of the time. Papillary carcinoma is the most common malignancy of the thyroid and has specific nuclear features that are easily identified on cytologic samples. Other malignancies that can be diagnosed on cytology with high accuracy include medullary carcinomas, lymphomas, and metastatic carcinomas. Papillary carcinoma is characterized on ThinPrep by sheets and papillary clusters of crowded cells with nuclear enlargement and molding, powdery chromatin, irregular nuclear membranes as evidenced by nuclear grooves and intranuclear cytoplasmic inclusions, and small but prominent and often eosinophilic nucleoli.[7] In contrast, medullary carcinoma is characterized by isolated monomorphic plasmacytoid cells that have a high nucleus:cytoplasm ratio, eccentric nuclei and coarsely granular chromatin with or without a prominent nucleolus. Small, inconspicuous granules fill the cytoplasm. Occasionally, the cells appear spindly, but show the same nuclear features. Lymphomas and metastatic carcinomas of the thyroid are much less common. Their cytologic features depend on their type and site of origin, respectively.

Suspicious for malignancy
When the specimen is not hypercellular or most, but not all, of the above described features for papillary and medullary carcinoma or other malignancy are present, it is reported to be suspicious for malignancy. The positive predictive value (malignancy rate on histology) of “suspicious for papillary carcinoma” ranges from 54 to 84% in the literature, depending on whether another less than definitive category, such as indeterminate, is in the scheme. [7, 8, 9, 10] When an indeterminate category is included in addition to the suspicious category, the PPV for the suspicious category is 64% or higher.[7, 9, 10] Since other types of carcinomas in the thyroid are much less common, their positive predictive values of a suspicious diagnosis have not been reported.

Indeterminate for malignancy
This category in our lab includes those specimens that have a predictive value of malignancy on histology less than 50% (mostly less than 30%) and greater than 10%.[6, 7] This includes those specimens that show a few features of papillary carcinoma, but are insufficient for a suspicious diagnosis.[7] Its positive predictive value ranges from 20 to 54% in the literature.[7, 9, 10, 11] These lesions often represent follicular variant of papillary carcinoma. This diagnostic category also includes follicular and Hürthle cell neoplasms, characterized by scant colloid and follicular cells in microfollicles and crowded groups or single Hürthle cells. The positive predictive value of these lesions for a carcinoma varied from 2 to 91% in the literature,[6, 9, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27] probably due to different definitions of these terms and varying criteria in their scheme as well as on histologic diagnosis, but is less than 30% in most but a few reports.[10, 15, 22, 24, 27]

Most probably benign
This category includes those follicular lesions that show a macrofollicular or mixed micro- and macrofollicular pattern with some to abundant colloid in the background. On ThinPrep macrofollicles are seen as sheets of dozens of evenly spaced follicular cells with good distance between nuclei. The significance of single follicular cells on ThinPrep is uncertain as they are seen in an otherwise micro- or macrofollicular pattern. Since the probability for these lesions to show malignancy (follicular variant of papillary carcinoma or follicular carcinoma) on histology is low but not exactly zero, ranging from 0 to 43% in the literature [6, 9, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 24, 25, 26, 27] with all but three[14, 16, 27] less than 6%, we therefore call it most probably benign instead of unequivocally benign.

Negative for malignant cells consistent with Hashimoto’s thyroiditis
We have found that ThinPrep is not optimal for the diagnosis of thyroiditis.[6] Hashimoto’s thyroiditis is characterized by sheets or groups of follicular cells with varying degrees of Hürthle cell changes in a background of varying number of lymphocytes and plasma cells with occasional lymphoid and follicular center aggregates. Since lymphocytic/Hashimoto’s thyroiditis is a common finding in the thyroid, sampling is critical in ruling out other co-existing more significant lesions.

Sub-optimal cellularity but shows features suggestive of …
Since thyroid FNA essentially triages patients for either surgery or follow-up, we would like to have more than adequate cellularity for a definitive diagnosis for this triage. If the cellularity is sub-optimal (but enough to suggest a diagnosis), we would start the report with this qualifier and then follow with any one of the above categories. This category includes those specimens that show cyst contents (macrophages) with very few follicular cells. We do not have a quantitative threshold for this category but rely on a combination of features, including the amount of colloid, cellular arrangement as well cytologic features, to make this decision.

Non-diagnostic
This category is usually reserved for those specimens that show virtually no, or very few, follicular cells.

References

  1. Cramer H. Fine-needle aspiration cytology of the thyroid: an appraisal. Cancer 2000; 90(6):325-9.
  2. Mazzaferri EL. Management of a solitary thyroid nodule [see comments]. N Engl J Med 1993; 328(8):553-9.
  3. Biscotti CV, Hollow JA, Toddy SM, Easley KA. ThinPrep versus conventional smear cytologic preparations in the analysis of thyroid fine-needle aspiration specimens. Am J Clin Pathol 1995; 104(2):150-3.
  4. Frost AR, Sidawy MK, Ferfelli M, et al. Utility of thin-layer preparations in thyroid fine-needle aspiration: diagnostic accuracy, cytomorphology, and optimal sample preparation. Cancer 1998; 84(1):17-25.
  5. Afify AM, Liu J, Al-Khafaji BM. Cytologic artifacts and pitfalls of thyroid fine-needle aspiration using ThinPrep: a comparative retrospective review. Cancer 2001; 93(3):179-86.
  6. Tulecke MA, Wang HH. ThinPrep for cytologic evaluation of follicular thyroid lesions: correlation with histologic findings. Diagn Cytopathol 2004; 30(1):7-13.
  7. Zhang Y, Fraser JL, Wang HH. Morphologic predictors of papillary carcinoma on fine-needle aspiration of thyroid with ThinPrep preparations. Diagn Cytopathol 2001; 24(6):378-83.
  8. Chen H, Zeiger MA, Clark DP, Westra WH, Udelsman R. Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration? J Am Coll Surg 1997; 184(6):605-10.
  9. Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol 2001; 116(4):477-82.
  10. Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 2002; 235(5):656-62; discussion 662-4.
  11. Renshaw AA. Focal features of papillary carcinoma of the thyroid in fine-needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol 2002; 118(2):208-10.
  12. Al-Rikabi AC, Al-Omran M, Cheema M, El-Khwsky F, Al-Nuaim A. Pattern of thyroid lesions and role of fine needle aspiration cytology (FNA) in the management of thyroid enlargement: a retrospective study from a teaching hospital in Riyadh. Apmis 1998; 106(11):1069-74.
  13. Baloch ZW, Tam D, Langer J, Mandel S, LiVolsi VA, Gupta PK. Ultrasound-guided fine-needle aspiration biopsy of the thyroid: role of on-site assessment and multiple cytologic preparations. Diagn Cytopathol 2000; 23(6):425-9.
  14. Boyd LA, Earnhardt RC, Dunn JT, Frierson HF, Hanks JB. Preoperative evaluation and predictive value of fine-needle aspiration and frozen section of thyroid nodules. J Am Coll Surg 1998; 187(5):494-502.
  15. Hawkins F, Bellido D, Bernal C, et al. Fine needle aspiration biopsy in the diagnosis of thyroid cancer and thyroid disease. Cancer 1987; 59(6):1206-9.
  16. Ko HM, Jhu IK, Yang SH, et al. Clinicopathologic analysis of fine needle aspiration cytology of the thyroid. A review of 1,613 cases and correlation with histopathologic diagnoses. Acta Cytol 2003; 47(5):727-32.
  17. Mandreker SR, Nadkarni NS, Pinto RG, Menezes S. Role of fine needle aspiration cytology as the initial modality in the investigation of thyroid lesions. Acta Cytol 1995; 39(5):898-904.
  18. Miller JM, Kini SR, Hamburger JI. The diagnosis of malignant follicular neoplasms of the thyroid by needle biopsy. Cancer 1985; 55(12):2812-7.
  19. Morgan JL, Serpell JW, Cheng MS. Fine-needle aspiration cytology of thyroid nodules: how useful is it? ANZ J Surg 2003; 73(7):480-3.
  20. Prinz RA, O’Morchoe PJ, Barbato AL, et al. Fine needle aspiration biopsy of thyroid nodules. Ann Surg 1983; 198(1):70-3.
  21. Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 2000; 90(6):357-63.
  22. Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 2004; 60(1):21-8.
  23. Silverman JF, West RL, Larkin EW, et al. The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm. Cancer 1986; 57(6):1164-70.
  24. La Rosa GL, Belfiore A, Giuffrida D, et al. Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer 1991; 67(8):2137-41.
  25. DeMay RM. Follicular lesions of the thyroid. W(h)ither follicular carcinoma? Am J Clin Pathol 2000; 114(5):681-3.
  26. Mateša N, Tabain I, Dabelic N, Petric V, Kusic Z. Diagnostic relevance of fine needle aspiration cytology for follicular lesions of the thyroid: retrospective study. Croat Med J 2002; 43(5):606-9.
  27. Blansfield JA, Sack MJ, Kukora JS. Recent experience with preoperative fine-needle aspiration biopsy of thyroid nodules in a community hospital. Arch Surg 2002; 137(7):818-21.

Positive for Papillary Carcinoma

CytologyStuff